This information was published on 2026-03-05T23:14:11 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2626754 (IR 1901831) |
| (220) |
14 Jan 2026
|
| (300) |
US, 15 Jul 2025, 99284130
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for use in oncology. |
| (540) | REZZVARITY |
| (550) | Word |
| (730) |
Immunome, Inc.
|
Find out more about publications on the About page.